Marco Bo

1.1k total citations
45 papers, 827 citations indexed

About

Marco Bo is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Marco Bo has authored 45 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 7 papers in Public Health, Environmental and Occupational Health and 6 papers in Infectious Diseases. Recurrent topics in Marco Bo's work include Mycobacterium research and diagnosis (8 papers), Reproductive Health and Contraception (5 papers) and Multiple Sclerosis Research Studies (4 papers). Marco Bo is often cited by papers focused on Mycobacterium research and diagnosis (8 papers), Reproductive Health and Contraception (5 papers) and Multiple Sclerosis Research Studies (4 papers). Marco Bo collaborates with scholars based in Italy, Argentina and United Kingdom. Marco Bo's co-authors include Leonardo A. Sechi, Gian Luca Erre, Giuseppe Passiu, Juan Pablo Isacch, Carla Maria Zotti, Erminia Ferrario, Gianfranco Fonte, Fabrizio Fabris, Mauro Zanocchi and L Pernigotti and has published in prestigious journals such as SHILAP Revista de lepidopterología, Stroke and Scientific Reports.

In The Last Decade

Marco Bo

45 papers receiving 807 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco Bo Italy 18 187 166 155 131 108 45 827
Beatriz Sobrino Spain 22 119 0.6× 777 4.7× 121 0.8× 106 0.8× 44 0.4× 46 1.8k
Silvano Presciuttini Italy 25 156 0.8× 382 2.3× 142 0.9× 31 0.2× 122 1.1× 105 1.8k
Matthew P. Conomos United States 16 80 0.4× 549 3.3× 43 0.3× 51 0.4× 63 0.6× 26 1.5k
Daniel B. Mirel United States 22 154 0.8× 578 3.5× 41 0.3× 182 1.4× 63 0.6× 32 1.6k
Anthony W. Ryan Ireland 18 160 0.9× 234 1.4× 22 0.1× 269 2.1× 49 0.5× 42 1.4k
Antonel Olckers South Africa 15 84 0.4× 781 4.7× 152 1.0× 122 0.9× 30 0.3× 28 1.8k
Eduardo Tarazona‐Santos Brazil 24 93 0.5× 353 2.1× 37 0.2× 30 0.2× 71 0.7× 88 1.7k
Marı́a Brión Spain 27 65 0.3× 869 5.2× 468 3.0× 87 0.7× 111 1.0× 90 2.1k
Albert Min‐Shan Ko Taiwan 24 170 0.9× 461 2.8× 18 0.1× 53 0.4× 132 1.2× 47 1.8k
Héctor Rangel‐Villalobos Mexico 26 134 0.7× 586 3.5× 70 0.5× 37 0.3× 50 0.5× 134 2.0k

Countries citing papers authored by Marco Bo

Since Specialization
Citations

This map shows the geographic impact of Marco Bo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Bo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Bo more than expected).

Fields of papers citing papers by Marco Bo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Bo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Bo. The network helps show where Marco Bo may publish in the future.

Co-authorship network of co-authors of Marco Bo

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Bo. A scholar is included among the top collaborators of Marco Bo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Bo. Marco Bo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bo, Marco, Alessandra Carta, Chiara Cipriani, et al.. (2024). HERVs Endophenotype in Autism Spectrum Disorder: Human Endogenous Retroviruses, Specific Immunoreactivity, and Disease Association in Different Family Members. Microorganisms. 13(1). 9–9. 3 indexed citations
2.
Bo, Marco, et al.. (2024). The Humoral Immune Response against Human Endogenous Retroviruses in Celiac Disease: A Case–Control Study. Biomedicines. 12(8). 1811–1811. 2 indexed citations
3.
Coradduzza, Donatella, Marco Bo, Emanuela Azara, et al.. (2023). Decoding the Microbiome’s Influence on Rheumatoid Arthritis. Microorganisms. 11(9). 2170–2170. 19 indexed citations
4.
Meloni, Tullio, Seyedesomaye Jasemi, Elena Rita Simula, et al.. (2022). HERV-K Envelope Protein Induces Long-Lasting Production of Autoantibodies in T1DM Patients at Onset in Comparison to ZNT8 Autoantibodies. Pathogens. 11(10). 1188–1188. 10 indexed citations
5.
Zhang, Pengfei, Stephanie Allen, Marco Bo, et al.. (2021). In vivo Evaluation of a Newly Synthesized Acetylcholinesterase Inhibitor in a Transgenic Drosophila Model of Alzheimer’s Disease. Frontiers in Neuroscience. 15. 691222–691222. 13 indexed citations
6.
Jasemi, Seyedesomaye, et al.. (2021). Humoral Response to Microbial Biomarkers in Rheumatoid Arthritis Patients. Journal of Clinical Medicine. 10(21). 5153–5153. 16 indexed citations
7.
8.
Bo, Marco, Gian Luca Erre, Horacio Bach, et al.. (2019). <p>PtpA and PknG Proteins Secreted by <em>Mycobacterium avium</em> subsp. <em>paratuberculosis</em> are Recognized by Sera from Patients with Rheumatoid Arthritis: A Case–Control Study</p>. Journal of Inflammation Research. Volume 12. 301–308. 25 indexed citations
9.
Bo, Marco, Lorena Charrier, Sabina Bartalini, et al.. (2018). Access to social security benefits among multiple sclerosis patients in Italy: A cross-sectional study.. Multiple Sclerosis and Related Disorders. 24. 107–112. 5 indexed citations
10.
Bo, Marco, Magdalena Niegowska, Gian Luca Erre, et al.. (2018). Rheumatoid arthritis patient antibodies highly recognize IL-2 in the immune response pathway involving IRF5 and EBV antigens. Scientific Reports. 8(1). 1789–1789. 26 indexed citations
11.
12.
13.
Bo, Marco, Carla Maria Zotti, & Lorena Charrier. (2017). The no correlation argument: can the morality of conscientious objection be empirically supported? the Italian case. BMC Medical Ethics. 18(1). 64–64. 12 indexed citations
14.
Mameli, Giuseppe, Gian Luca Erre, Silvia Mura, et al.. (2017). Identification of a HERV-K env surface peptide highly recognized in Rheumatoid Arthritis (RA) patients: a cross-sectional case–control study. Clinical & Experimental Immunology. 189(1). 127–131. 46 indexed citations
15.
Bo, Marco, Carla Maria Zotti, & Lorena Charrier. (2015). Conscientious objection and waiting time for voluntary abortion in Italy. The European Journal of Contraception & Reproductive Health Care. 20(4). 272–282. 25 indexed citations
16.
Bo, Marco, Ivo Casagranda, Lorena Charrier, & Maria Michela Gianino. (2012). Availability of emergency contraception: A survey of hospital emergency department gynaecologists and emergency physicians in Piedmont, Italy. The European Journal of Contraception & Reproductive Health Care. 17(5). 373–382. 3 indexed citations
17.
García, Germán Ó., et al.. (2010). Social Learning in the Caracara Chimango,Milvago chimango(Aves: Falconiformes): an Age Comparison. Ethology. 116(8). 722–735. 23 indexed citations
18.
Zanocchi, Mauro, et al.. (1992). [Prevalence and risk factors of carotid and femoral atherosclerosis in a sample of the city of Turin].. PubMed. 83(9). 481–8. 1 indexed citations
19.
Bo, Marco, et al.. (1991). One year experiencee in the treatmeent of elderly hypercholesterolemic patients with pravastatin. Current Therapeutic Research. 50(2). 151–158. 1 indexed citations
20.
Zhang, Shujuan, Yumin Luo, & Marco Bo. (1991). Vertigo treated with scalp acupuncture.. PubMed. 11(1). 26–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026